These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 17145033

  • 1. [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
    Conesa Mateos A, Rotés Sala D, Almirall Bernabé M, Carbonell Abelló J.
    Med Clin (Barc); 2006 Oct 28; 127(16):635-6. PubMed ID: 17145033
    [No Abstract] [Full Text] [Related]

  • 2. The use of zoledronic acid for Paget's disease of bone.
    Maricic M.
    Curr Osteoporos Rep; 2006 Mar 28; 4(1):40-4. PubMed ID: 16527007
    [Abstract] [Full Text] [Related]

  • 3. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM, Scott LJ.
    Drugs; 2007 Mar 28; 67(5):793-804. PubMed ID: 17385948
    [Abstract] [Full Text] [Related]

  • 4. Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.
    Polyzos SA.
    Clin Rheumatol; 2011 Jan 28; 30(1):149-50. PubMed ID: 21053036
    [No Abstract] [Full Text] [Related]

  • 5. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
    Gennari L, Merlotti D, Mossetti G, Rendina D, De Paola V, Martini G, Nuti R.
    Mini Rev Med Chem; 2009 Aug 28; 9(9):1052-63. PubMed ID: 19689402
    [Abstract] [Full Text] [Related]

  • 6. Zoledronic acid for treatment of Paget's disease of bone.
    Devogelaer JP, Manicourt DH.
    Expert Opin Pharmacother; 2007 Nov 28; 8(16):2863-9. PubMed ID: 17956205
    [Abstract] [Full Text] [Related]

  • 7. Zoledronic acid for Paget's disease of bone.
    Maricic M.
    Drugs Today (Barc); 2007 Dec 28; 43(12):879-85. PubMed ID: 18174973
    [Abstract] [Full Text] [Related]

  • 8. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar 28; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of Paget's disease of bone with zoledronic acid].
    Body JJ, Sternon J.
    Rev Med Brux; 2005 Mar 28; 26(6):513-7. PubMed ID: 16454155
    [Abstract] [Full Text] [Related]

  • 10. Zoledronate treatment in active Paget's disease.
    Chung G, Keen RW.
    Ann Rheum Dis; 2003 Mar 28; 62(3):275-6. PubMed ID: 12594123
    [No Abstract] [Full Text] [Related]

  • 11. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM.
    Nat Clin Pract Rheumatol; 2006 Apr 28; 2(4):186-7. PubMed ID: 16932682
    [No Abstract] [Full Text] [Related]

  • 12. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F.
    Clin Exp Rheumatol; 2007 Apr 28; 25(3):464-6. PubMed ID: 17631747
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of Paget's disease of bone: importance of the zoledronic acid].
    Griz L, Colares V, Bandeira F.
    Arq Bras Endocrinol Metabol; 2006 Oct 28; 50(5):845-51. PubMed ID: 17160207
    [Abstract] [Full Text] [Related]

  • 14. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events].
    Grados D, Martínez-Morillo M, Holgado S, Erra A.
    Med Clin (Barc); 2014 May 20; 142(10):469-70. PubMed ID: 24120108
    [No Abstract] [Full Text] [Related]

  • 15. Zoledronate in the treatment of Paget's disease.
    Siris E.
    Br J Clin Pract Suppl; 1996 Sep 20; 87():19-20; discussion 22. PubMed ID: 8995014
    [No Abstract] [Full Text] [Related]

  • 16. Images in clinical medicine. Saber tibia in Paget's disease of bone.
    Gonçalves MJ, Romão VC.
    N Engl J Med; 2014 Dec 18; 371(25):2417. PubMed ID: 25517708
    [No Abstract] [Full Text] [Related]

  • 17. Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget's disease.
    Watts MR, Ellims AH, Eccleston DS.
    Med J Aust; 2014 Feb 17; 200(3):150. PubMed ID: 24528425
    [No Abstract] [Full Text] [Related]

  • 18. Bifocal sarcomatous transformation of Paget's disease: a case report.
    El Mansouri L, Meadeb JM, Albert JD, Duval H, Chalès G, Hajjaj-Hassouni N, Guggenbuhl P.
    Joint Bone Spine; 2009 Oct 17; 76(5):574-5. PubMed ID: 19801199
    [No Abstract] [Full Text] [Related]

  • 19. Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.
    Polyzos SA, Anastasilakis AD, Anagnostis P, Kita M, Arsos G, Moralidis E, Papatheodorou A, Terpos E.
    Endokrynol Pol; 2012 Oct 17; 63(4):312-5. PubMed ID: 22933168
    [Abstract] [Full Text] [Related]

  • 20. [Paget's disease of bone: diagnosis and treatment].
    Winter EM, Hamdy NA, de Jongh RT, Eekhoff EM, Zillikens MC, Appelman-Dijkstra NM.
    Ned Tijdschr Geneeskd; 2016 Oct 17; 160():D254. PubMed ID: 27650015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.